TrialPloS one2026

Investigating the effects of cannabinoids for the reduction of inflammation and sickle cell disease pain (CRISP); A protocol for a randomized double-blind placebo-controlled study.

Jordan Bellis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.